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The CACCC-box binding protein erythroid Krüppel-like factor (EKLF/KLF1) is a master regulator that directs the expression of
many important erythroid genes. We have previously shown that EKLF drives transcription of the gene for a second KLF, basic
Krüppel-like factor, or KLF3. We have now tested the in vivo role of KLF3 in erythroid cells by examining Klf3 knockout mice.
KLF3-deficient adults exhibit a mild compensated anemia, including enlarged spleens, increased red pulp, and a higher percent-
age of erythroid progenitors, together with elevated reticulocytes and abnormal erythrocytes in the peripheral blood. Impaired
erythroid maturation is also observed in the fetal liver. We have found that KLF3 levels rise as erythroid cells mature to become
TER119. Consistent with this, microarray analysis of both TER119 and TER119 erythroid populations revealed that KLF3 is
most critical at the later stages of erythroid maturation and is indeed primarily a transcriptional repressor. Notably, many of the
genes repressed by KLF3 are also known to be activated by EKLF. However, the majority of these are not currently recognized as
erythroid-cell-specific genes. These results reveal the molecular and physiological function of KLF3, defining it as a feedback re-
pressor that counters the activity of EKLF at selected target genes to achieve normal erythropoiesis.
The Krüppel-like factor (KLF) transcription factors are charac-terized by three highly conserved C-terminal Cys2-His2 zinc
finger motifs that bind CACCC boxes and other GC-rich elements
in control regions of DNA (15). The N-terminal functional do-
mains are less conserved, and individual KLFs are able to recruit
different coregulators to function as transcriptional activators
and/or repressors. For example, recruitment of the acetyltrans-
ferases P/CAF and p300/CBP by erythroid Krüppel-like factor
(EKLF/KLF1) potentiates its activation of the -globin gene (33,
34), while Krüppel-like factor 3 (KLF3/BKLF) utilizes the co-
repressor C-terminal binding protein (CtBP) to silence gene ex-
pression (5, 29).
EKLF, the founding member of the KLF family, plays an essen-
tial role in many aspects of erythropoiesis. EKLF is a potent tran-
scriptional activator that binds to 5=-NCNCNCCCN-3= motifs of
DNA (7, 28), and as its name suggests, it is almost exclusively
expressed in erythroid cells (12). Most notably, EKLF activates
expression of the adult -globin gene (12), and as a result, mice
lacking EKLF die in utero at around embryonic day 14.5 from
lethal -thalassemia (13, 18). Microarray and chromatin immu-
noprecipitation-sequencing (ChIP-Seq) studies have further re-
vealed that EKLF regulates the expression of many erythroid-cell-
specific genes, including genes involved in heme biosynthesis, red
blood cell proliferation, and membrane integrity (1, 4, 11, 19–21,
28). One gene which has consistently emerged as an EKLF target in
these studies is that encoding another member of the KLF family,
Klf3.
Klf3 was initially cloned from erythroid cells in a screen for
factors with homology to the DNA-binding domain of EKLF (3,
16). EKLF and KLF3 have similar DNA-binding preferences,
showing high-affinity interactions with many of the same ery-
throid promoter CACCC boxes in vitro, such as the -globin gene
promoter (3). Whereas EKLF can function as a potent activator of
transcription, KLF3 has primarily been shown to repress tran-
scription via the recruitment of CtBP and associated chromatin-
modifying enzymes (5, 24, 29, 30).
KLF3 is expressed in a wide range of cells; however, it is partic-
ularly abundant in erythroid tissue (16). This is due in part to the
fact that the Klf3 gene possesses two promoters: an upstream pro-
moter that is active in a range of tissues and a downstream, ery-
throid-cell-specific promoter that has been shown by EMSA,
ChIP, and ChIP-Seq to be directly bound by EKLF (8, 28). Impor-
tantly, EKLF functionally drivesKlf3 expression, as KLF3 levels are
significantly reduced in Eklf / fetal liver, and restoring EKLF in
EKLF-deficient cell lines leads to rapid upregulation of Klf3 tran-
scription (8). Taken together, the high erythroid expression of
KLF3, its erythroid-cell-specific promoter, and its dependence on
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EKLF implicate KLF3 in erythropoiesis. Furthermore, given the
similar DNA-binding preferences of EKLF and KLF3, this raises
the possibility that these two factors operate in a feedback circuit
to fine-tune gene expression during erythroid cell maturation.
To test the physiological role of KLF3 in vivo, we examined
erythroid development in the fetal liver and in the bone marrow,
spleen, and peripheral circulation of adult Klf3/ mice. While
Klf3/ mice have been shown to display defects in adipogenesis
and B-cell lymphopoiesis (26, 31), here we report for the first time
the erythroid phenotype of Klf3/mice. Erythroid maturation is
impaired in Klf3/ fetal liver, while reticulocytosis and an in-
crease in erythroid nuclear inclusions (Howell-Jolly bodies) are
apparent in the peripheral blood of adult Klf3/ mice. In addi-
tion, there is a significant increase in the percentage of CD71
TER119 proerythroblasts in the spleen in the absence of KLF3,
indicative of compensatory erythropoiesis. Taken together, these
observations are consistent with loss of KLF3 leading to defective
erythropoiesis and compensated anemia.
To understand the molecular mechanisms underlying KLF3’s
role in erythropoiesis, we employed a microarray-based approach
comparing sorted Klf3/ and Klf3/ fetal liver erythroid popu-
lations. This analysis revealed a set of genes that are significantly
derepressed in the absence of KLF3, consistent with the view that
KLF3 serves predominantly as a transcriptional repressor. The
comparison of sorted TER119 and TER119 cells also revealed
that KLF3 expression is low in erythroid progenitors and is subse-
quently upregulated as erythroid cells mature. In agreement with
this, we found that few genes are deregulated in Klf3/ TER119
progenitors, in noticeable contrast to the derepression of many
target genes in more mature TER119 erythroblasts.
A comparison of genes deregulated following loss of KLF3 with
those known to be regulated by EKLF revealed many shared tar-
gets. The majority of these genes have no known roles in erythroid
biology. This raises the possibility that KLF3 serves to focus the
activity of EKLF by preventing the promiscuous activation of non-
erythroid CACCC box genes during erythroid maturation. Taken
together, these findings indicate that KLF3 is required for normal
erythropoiesis and suggest that the balance of activating and re-
pressing KLFs in erythroid tissue is necessary for the precise reg-
ulation of erythroid differentiation.
MATERIALS AND METHODS
Klf3/ and Eklf / mice. Ethics approval was obtained from the Ani-
mal Care and Ethics Committee, University of New South Wales, ap-
proval no. 09/128A. Generation of Klf3/ mice has been described pre-
viously (26). Briefly, ablation of Klf3 was achieved by replacing a genomic
segment between intron 4 and exon 6 of the wild-type sequence with a
neomycin resistance gene (neo) construct. Klf3/ mice had previously
been backcrossed for more than 10 generations to ensure a pure FVB/NJ
strain (26). The Eklf / mouse line has also been described previously
(18).
Full blood count analysis. Peripheral blood was collected from
Klf3/ and Klf3/ mice via cardiac puncture into EDTA-coated Vacu-
ettes (Greiner Bio-One), with heparin included at 2.5 U/ml blood. Full
blood count analysis was performed by the Veterinary Pathology Diag-
nostic Services (VPDS) unit, University of Sydney.
Erythrocyte life span assay. N-Hydroxysuccinimide biotin was dis-
solved at 50 mg/ml inN,N,-dimethylacetamide. This was administered via
a single tail vein injection at a dose of 50 mg/kg, diluted in 250 l saline
solution immediately prior to use. To assess erythrocyte life span, 30 l
peripheral blood was obtained from the tail vein of treated mice at regular
intervals following in vivo biotin labeling. Samples were then analyzed by
flow cytometry, following staining with streptavidin–R-phycoerythrin
and anti-TER119-V450 antibody (BD Bioscience).
Cytological analysis. Blood smears were air dried, fixed in methanol
for 15 min, stained in May-Grünwald solution (5 min) followed by Gi-
emsa solution (15 min), and finally washed with distilled water. The slides
were allowed to air dry before mounting with DePeX for storage. Spleens
were dissected from litter-matched, 12-week-old Klf3/ and Klf3/
mice and placed into 20-spleen-volume 10% neutral buffered formalin
for 24 h. Spleens were stained with hematoxylin and eosin (H&E) and
were sectioned at the Veterinary Pathology Diagnostic Services (VPDS)
unit, University of Sydney.
Flow cytometry of erythrocyte populations. Flow cytometry was per-
formed using either FACSCalibur or LSRFortessa flow cytometers (BD
Bioscience), and data were analyzed using FlowJo v7.6.5 (TreeStar) soft-
ware. TER119 and CD71 (clone R17217) antibodies were supplied by BD
Bioscience and titrated to optimal concentrations. Reticulocytes were
identified by including thiazole orange (0.1 g/ml).
B1.6 cells. Culture of line B1.6 erythroblasts and tamoxifen-induced
rescue of EKLF nuclear activity in these cells were performed as previously
described (2, 8).
Purification of erythroid cell populations, cDNA synthesis, and
real-time PCR. TER119 and TER119 cells were purified from E14.5
fetal liver using magnet-activated cell sorting with anti-TER119 Mi-
crobeads (Miltenyi Biotech) by negative depletion (LD columns) and pos-
itive selection (MS columns), respectively, as per the supplier’s instruc-
tions. Total RNA was extracted using TRI reagent (Sigma, St. Louis, MO)
and RNeasy kits (Qiagen, Victoria, Australia) and treated with DNase as
described previously (8). cDNA was synthesized using a SuperScript
VILO cDNA synthesis kit (Invitrogen, Carlsbad, CA). Primers were de-
signed using PrimerExpress v3.0 (Applied Biosystems, Foster City, CA) as
previously described (8) and synthesized by Sigma-Aldrich. Primers for
the 18S and Klf3 genes have been described previously (8). Primer se-
quences for other genes are as follows: Klf8, 5=-CCAAAAGCTCTCACCT
GAAAGC-3= and 5=-AGCGAGCAAATTTCCAGGAA-3=; Lgals3, 5=-GAT
CACAATCATGGGCACAG-3= and 5=-ATTGAAGCGGGGGTTAAAGT-
3=; Fam132a, 5=-GGTCTTCACAGTGCAGGTTCAG-3= and 5=-GACTG
CCCCAGAACTGTTGTC-3=; Epo, 5=-CAGCTAGGCGCGGAGATG-3=
and 5=-AATCAGTAGCAAGGAGAGTAAAAGCA-3=. Quantitative real-
time PCR runs were performed in triplicate with Power SYBR green PCR
Master Mix and the 7500 fast real-time PCR system (Applied Biosystems)
as described previously (9). Data analysis was performed using 7500 soft-
ware v2.0.4 (Applied Biosystems).
Microarray analysis. Total RNA was purified from TER119 and
TER119 E14.5 fetal liver cells (Klf3/ andKlf3/) or whole E13.5 fetal
liver (Eklf / and Eklf /) as described above. RNA was subsequently
ethanol precipitated and washed with 75% ethanol in DEPC-treated de-
ionized water for further purification. RNA was then subjected to whole-
transcript sense labeling and hybridized to Affymetrix GeneChip 1.0 ST
mouse gene arrays (Affymetrix, Santa Clara, CA). Microarray preparation
and scanning were performed by the Ramaciotti Centre, University of
New South Wales, New South Wales, Australia. Microarray data were
analyzed using Partek genomic suite v6.5 (Partek Inc., St. Louis, MO).
Microarray CEL files were imported into Partek and normalized using the
robust multiarray average (RMA) algorithm. After confirming array qual-
ity (Affymetrix built-in controls and principal components analysis), dif-
ferential gene expression was calculated and tested for significance using a
1-way analysis of variance (ANOVA). Gene expression P values were cor-
rected for multiple testing using a false discovery rate (FDR) threshold of
0.2. Genes passing the threshold and having a change greater than 2-fold
were considered to be significantly differentially expressed. Hierarchical
clustering was performed using this gene set with Euclidean distance and
average linkage as set clustering parameters.
Assignation of putative EKLF/KLF3 shared target genes. Table S1 in
the supplemental material shows the list of genes that are derepressed
2-fold (0.2 FDR) in Klf3/ TER119 E14.5 fetal liver cells. A propor-
Funnell et al.
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tion of these genes have been designated as putative EKLF targets accord-
ing to one or more of the following criteria: they contain or are most
proximal to one or more of the set of 1,380 declared peaks in the EKLF
ChIP-Seq study by Tallack et al. (28); they are occupied by EKLF and, in
addition, are expressed at significant levels in either TER119 progenitor
cells or TER119 erythroblasts (from E13.5 fetal liver) in the EKLF ChIP-
Seq study by Pilon et al. (19); their expression is declared as significantly
altered in the EKLF microarray studies by Pilon et al. (20) and Borg et al.
(1); their expression is dysregulated2-fold in the EKLF microarray stud-
ies by Hodge et al. (11) and Drissen et al. (4); they have previously been
validated as an EKLF target gene in vivo as described by Eaton et al. (5); or
they display 2-fold deregulation in our own microarray analysis of
Eklf/ E13.5 fetal liver cells or by qRT-PCR analysis of tamoxifen-in-
duced compared to uninduced B1.6 cells.
Chromatin immunoprecipitation. ChIP was conducted on Klf3/
murine embryonic fibroblasts, stably transduced using a murine stem cell
virus retroviral delivery system containing V5-epitope tagged KLF3 or an
empty vector control. Approximately 1  107 cells were grown to 80%
confluence in Dulbecco’s modified Eagle medium (DMEM), then fixed
with 1% formaldehyde for 10 min, and quenched by the addition of 2 M
glycine. Following Dounce treatment in 5.4 ml cytoplasmic lysis buffer
(20 mM Tris [pH 8.0], 50 mM NaCl, 1 mM EDTA, and 1% Igepal CA-
630), nuclei were resuspended in 1.8 ml sonication buffer (20 mM Tris
[pH 8.0], 150 mM NaCl, 1 mM EDTA, 0.5% sodium deoxycholate, 0.2%
sodium dodecyl sulfate [SDS], and 1% Igepal CA-630) and sonicated for 8
min in a Bioruptor (Diagenode, Belgium). Input samples (18 l each)
were retained for DNA extraction. Sonicate was diluted 1/10 in ChIP
dilution buffer (20 mM Tris [pH 8.0], 150 mM NaCl, 1 mM EDTA, and
1% Igepal CA-630), and 4 l anti-V5 antibody (Invitrogen) was added
before incubation for 2 h at 4°C. A 50-l portion of washed protein G
Dynabeads (Invitrogen) was added, and incubation continued for a fur-
ther 30 min. Dynabeads were washed once each with low-salt buffer (20
mM Tris [pH 8.0], 150 mM NaCl, 1 mM EDTA, and 1% Igepal CA-630),
high-salt buffer (20 mM Tris [pH 8.0], 500 mM NaCl, 1 mM EDTA and
1% Igepal CA-630), and LiCl buffer (20 mM Tris [pH 8.0], 250 mM LiCl,
1 mM EDTA, 0.5% Igepal CA-630, and 0.5% sodium deoxycholate) and
then twice with low-salt buffer. DNA was extracted from input and IP
samples using an IPure kit (Diagenode, Belgium). Real-time PCR was
performed on duplicate-input and IP samples using the CT method to
determine fold enrichment of IP over input. Primer sequences identifying
positive (0.2 kb) and negative (4.5 kb) control sequences in the Klf8
promoter 1a are as previously described (5). Primer sequences for other
genes are as follows: Lgals3, 5=-TGGAAAAACACCCGTGCCTCTGA-3=
and 5=-CAGTGCCTACGCCCAGATGACTC-3=; Fam132a, 5=-GATTCG
CTTCCCTGGAGGTGTGG-3= and 5=-GCCCAGTCTCTGGTCTCCTC
TCT-3=.
Microarray data accession numbers. Microarray data are available in
the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov
/projects/geo) under accession numbers GSE35592 (KLF3 E14.5 fetal liver
arrays) and GSE35594 (EKLF E13.5 fetal liver arrays).
RESULTS
Loss of KLF3 results in a mild compensated anemia. We first
performed full blood counts on peripheral blood collected from
20 Klf3/ and 20 Klf3/ age-matched adult mice (Fig. 1A to G).
The examination of this cohort revealed subtle but consistent al-
terations in blood parameters. Klf3/ erythrocytes contain less
mean cell hemoglobin than Klf3/ cells, and this appears to be
compensated for by an increase in red blood cell count and he-
matocrit. The mean corpuscular volume ofKlf3/ erythrocytes is
unchanged, indicating that the increased hematocrit reflects the
increase in red blood cell count, rather than effects on cell size. Full
blood count analysis also suggested significant reticulocytosis in
Klf3/mice, confirmed by flow cytometric analysis of peripheral
blood reticulocytes stained with thiazole orange (Fig. 1H). Addi-
tionally, peripheral blood smears from Klf3/ mice showed an
increase in the number of reticulocytes and revealed the presence
of nuclear inclusions (Howell-Jolly bodies [23]) in a number of
erythrocytes, again indicative of anemia (Fig. 2D). The presence of
a mild compensated anemia in Klf3/ mice is further supported
by increased expression of erythropoietin (Fig. 1I). We also inves-
tigated the life span of Klf3/ erythrocytes in vivo and found a
significant reduction in their half-life, a probable contributory
factor in the observed anemia (Fig. 1J). Finally, we also observed a
significant decrease in the number of circulating platelets in
Klf3/ mice (Fig. 1G), suggesting that KLF3 may influence lin-
eage decisions in common megakaryocyte-erythroid progenitors,
as has previously been shown for EKLF (27).
Erythroid defects in the spleen and bone marrow of Klf3/
mice. In the mouse, the adult spleen is both an erythrocyte reser-
voir and a site of erythropoiesis that is particularly active during
periods of erythroid stress. The spleens of Klf3/ animals ap-
peared larger than those of Klf3/ littermates (Fig. 2A). Measur-
ing spleen weight, which we normalized to body weight to account
for the small phenotype of Klf3/ mice (26), confirmed the in-
creased spleen size (Fig. 2A). We also examined H&E-stained sec-
tions of Klf3/ spleens and found considerable disruption to the
splenic architecture, with a notable increase in the proportion of
erythroid red pulp, at the expense of lymphoid white pulp (Fig. 2B
and C). This suggested that compensatory stress erythropoiesis
occurs in the spleens of Klf3/ mice. To confirm this, we stained
splenic erythrocytes for expression of CD71 and TER119 to dis-
tinguish nonerythroid cells (CD71lo TER119lo) and the various
maturing erythroid populations: proerythroblasts (CD71hi
TER119med), basophilic erythroblasts (CD71hi TER119hi), poly-
chromatophilic erythroblasts (CD71med TER119hi), and the more
mature orthochromatophilic erythroblast and reticulocyte
(CD71lo TER119hi) populations (25). We found that the absence
of KLF3 leads to an increase in the percentage of all of these ery-
throid cells, with the proerythroblast and basophilic erythroblast
populations showing the most significant changes (Fig. 3A). These
changes were accompanied by a significant decrease in the non-
erythroid compartment, consistent with the spleen sections. The
increase in the earlier erythroid populations is suggestive of ongo-
ing stress erythropoiesis in the spleens of Klf3/ mice.
We also examined erythropoiesis in the bone marrow of
Klf3/ mice, again by staining for expression of CD71 and
TER119 to identify maturing erythroid populations from pro-
erythroblast to reticulocyte. Although loss of KLF3 has a less dra-
matic effect in bone marrow than spleen, this analysis revealed a
reproducible and significant increase in the percentage of CD71hi
TER119med proerythroblasts in Klf3/ bone marrow (Fig. 3B),
again consistent with compensatory erythropoiesis. The less se-
vere disruption seen in the bone marrow of Klf3/ mice may
reflect the respective contributions of bone marrow and spleen to
stress erythropoiesis in the mouse. While homeostatic red blood
cell production occurs mainly in the bone marrow to ensure a
constant steady-state supply of cells, compensatory erythropoiesis
takes place predominantly in the spleen (14). Our data are consis-
tent with loss of KLF3 leading to significant compensatory re-
sponses mediated largely by the spleen.
Reduced cellular maturation in the fetal liver of Klf3/
mice. Fetal erythropoiesis proceeds through a number of stages
that can also be defined by staining erythrocytes for surface
EKLF/KLF1 and KLF3 in Erythropoiesis
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FIG 1 Peripheral red blood cell parameters of Klf3/ adult mice. (A to G) Full peripheral blood count analysis was performed on 20 Klf3/ and 20 Klf3/
mice, 10 to 20 weeks old. (H) Representative flow cytometry plot of four Klf3/ and four Klf3/ mice, showing peripheral blood stained with thiazole orange
and anti-TER119 antibody to determine reticulocyte percentage. (I) Expression levels of erythropoietin (Epo) in adult kidney fromKlf3/ (n 3),Klf3/ (n
2), and Klf3/ (n 2) mice were determined by qRT-PCR. Relative expression was normalized against 18S rRNA and the expression level in Klf3/ tissue was
set to 1.0. (J) Plot showing the relative survival rate of WT (n 3) and Klf3/ (n 3) erythrocytes tracked in vivo by biotin labeling. Error bars represent the
standard errors of the means. P values indicate the differences between two means: *, P	 0.05; **, P	 0.01. WT, wild type (Klf3/); KO, knockout (Klf3/).
Funnell et al.
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FIG 2 Abnormal splenic structure and erythropoiesis in Klf3/ mice. (A) Klf3/ spleens are larger than those of Klf3/ littermates (left). Klf3/ mice are
smaller than Klf3/ littermates (26), while normalized Klf3/ spleen weights are significantly increased (right; n 42 for each genotype). (B and C) Klf3/
spleens have increased red pulp at the expense of white pulp. Shown are representative sections from analysis of four Klf3/ (left) and four Klf3/mice (right)
stained with H&E at40 (B) and100 (C) magnification. Arrows indicate red pulp, and arrowheads show white pulp. (D) Increased prevalence of Howell-Jolly
bodies (arrows) and reticulocytes (arrowheads) in the peripheral blood ofKlf3/ animals. Shown are representative smears (magnification,1,000) comparing
Klf3/ (left) and Klf3/ (right) peripheral blood samples from analysis of 6 mice of each genotype, 12 to 16 weeks old. Error bars show the standard errors of
the means. P values indicate the differences between two means: **, P	 0.01. WT, wild type (Klf3/); KO, knockout (Klf3/).
EKLF/KLF1 and KLF3 in Erythropoiesis
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expression of CD71 and TER119 (32). At embryonic day 12.5
(E12.5), we did not detect any erythropoietic disruption in the
livers of Klf3/ mice (data not shown). However, by E14.5 some
modest differences that had not reached statistical significance
had emerged, with a reduced number of cells transitioning from
CD71hi TER119hi (basophilic erythroblasts) to CD71med
TER119hi chromatophilic and orthochromatophilic erythroblasts
(see Fig. S1 in the supplemental material). By E16.5, this disrup-
tion in fetal erythropoiesis was more pronounced, with a signifi-
cant increase in the percentage of Klf3/ CD71hi TER119hi cells
and an apparent defect in the development of the more mature
CD71med TER119hi and CD71lo TER119hi erythroblast and reticu-
FIG 3 Disrupted erythropoiesis in the spleen, bone marrow, and fetal liver of Klf3/ mice. Representative flow cytometry plots of Klf3/ and Klf3/ cells
stained with antibodies against CD71 and TER119 are shown. Klf3/ (left) and Klf3/ (center) cells were purified from spleen (A) and bone marrow (B) of 8-
to 13-week-old adults and from E16.5 fetal liver (C). (Right) Statistical analyses of flow cytometry data from several animals (spleen, n 10 for each genotype;
bone marrow, n  12 for each genotype; fetal liver, n  5 for each genotype). Error bars show standard errors of the means. P values indicate the differences
between two means: *, P	 0.05; **, P	 0.01. WT, wild type (Klf3/); KO, knockout (Klf3/).
Funnell et al.
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locyte populations (Fig. 3C). The accumulation of CD71hi
TER119hi cells in the fetal livers of Klf3/ mice is indicative of a
defect in the first wave of definitive erythropoiesis, which may in
part influence the later anemia seen in KLF3-deficient adult mice.
KLF3 represses genes at later stages of erythroid maturation.
KLF3 thus appears to be required for normal definitive erythro-
poiesis in both embryonic and adult erythroid tissues. We next
sought to identify the stage of erythroid maturation at which KLF3
might be most functionally relevant. We examined the levels of
Klf3 mRNA during the maturation of erythroid cells by compar-
ing sorted TER119 progenitors to more mature TER119 eryth-
roblasts and observed a significant 4.2-fold upregulation in Klf3
expression (Fig. 4). Specific examination of transcripts emanating
from the twoKlf3 promoters showed that the overall upregulation
of Klf3 was due to a 3.8-fold increase in expression from Klf3
promoter 1a and a 6.4-fold increase from the more EKLF-depen-
dent erythroid promoter 1b (Fig. 4) (8). Taken together, the re-
sults suggest that KLF3 expression rises during erythroid matura-
tion, consistent with increasing transcriptional activity of EKLF
regulating the terminal stages of erythroid differentiation (2, 28).
We next performed Affymetrix microarrays on fetal liver cells
from E14.5 Klf3/ and Klf3/ mice and analyzed both
TER119 progenitor cells and TER119 erythroblasts (see Fig. S2
in the supplemental material) in order to investigate the role of
KLF3 in regulating gene expression at different stages throughout
the erythroid maturation process. Here we confine our attention
to genes that show a 2-fold change in expression (P 	 0.05;
FDR 	 0.2). We found that in Klf3/ TER119 erythroid pro-
genitors, where KLF3 levels are relatively low, there was little de-
regulation of gene expression, with no genes being significantly
altered more than 2-fold (data not shown). In contrast, we found
that in the more mature TER119 erythroid cells, loss of KLF3 had
a noticeable effect, with the expression of 85 genes being signifi-
cantly derepressed (Fig. 5A). Interestingly, only three genes are
significantly downregulated in the absence of KLF3. These results
suggest that KLF3 primarily acts as a transcriptional repressor in
vivo, consistent with previous functional studies in vitro (17,
22, 29).
We then compared the expression of these 85 upregulated and
3 downregulated genes across 15 independent microarrays that
included TER119 and TER119 Klf3/ and Klf3/ samples
(Fig. 5B). Analysis of this heat map revealed genes which are reg-
ulated by KLF3 and which can broadly be categorized into three
groups. The first group includes genes whose expression is mildly
repressed or maintained at a relatively low level during erythroid
maturation (compare TER119 with TER119 wild-type sam-
ples). The second group contains genes whose expression in-
creases during erythroid differentiation. The increased expression
of these genes appears to be tempered by KLF3 during erythropoi-
esis, as Klf3/ TER119 cells exhibit marked upregulation of
these genes compared to wild-type TER119 cells. The final group
comprises genes whose expression is strongly repressed or si-
lenced during erythroid maturation.
These results suggest that KLF3 plays a complex role both in
fine-tuning the expression of some targets by moderate repression
and also in more dramatically silencing certain genes during the
maturation of TER119 progenitors into TER119 erythroblasts.
In each of these instances, ablation of KLF3 leads to unchecked
derepression of these genes in mature erythroid cells, emphasizing
KLF3’s complex contribution to maintaining a proper transcrip-
tional program in these cells.
One aspect of the role of KLF3 as a repressor that is active in the
later stages of erythropoiesis can be illustrated by considering its
effect on its best characterized target gene, Klf8 (5). We have pre-
viously reported that the transcriptional repressor KLF8 is up-
regulated in Klf3/ erythroid tissue (5) and as expected, we ob-
served an 8.3-fold increase in Klf8 expression in the Klf3/
TER119 microarrays. We also examined Klf8 expression during
cellular maturation by qRT-PCR by comparing mRNA from
sorted E14.5 TER119 progenitors and TER119 erythroblasts
(Fig. 6). We found that in Klf3/ cells, Klf8 levels decrease 7.7-
fold as progenitors mature into erythroblasts. This result fits well
with the increase in expression of KLF3 during cellular matura-
tion. In the absence of KLF3, we observed a modest 3.1-fold in-
crease inKlf8 in TER119 cells, contrasting with a striking 40-fold
derepression in TER119 erythroblasts (Fig. 6). Thus, KLF3-me-
diated repression is more prominent at this later stage of cellular
maturation.
KLF3 represses a subset of genes driven by EKLF. The related
family member EKLF has previously been shown to be indispens-
able for definitive erythropoiesis in the embryo. Loss of EKLF
causes erythropoiesis to arrest in the fetal liver, with erythroid
progenitors failing to progress past the CD71hi TER119lo stage of
maturation (20). Eklf / and Klf3/ mice thus display impair-
ments at similar stages during the erythropoietic differentiation
program. While many EKLF target genes have been discovered
primarily through microarray and ChIP-Seq analyses of Eklf /
and Eklf / fetal liver cells (4, 11, 19, 20, 28), the target genes of
KLF3 have hitherto largely remained unknown. Given their sim-
ilar DNA-binding specificities, EKLF and KLF3 have been postu-
lated to regulate an overlapping cohort of target genes (3, 8).
Accordingly, we asked whether any of the KLF3-dependent
genes from the TER119 arrays are known to be regulated by
EKLF. To do this, we first prepared a list of EKLF target genes by
compiling data from several previously published studies, includ-
ing microarray and ChIP-Seq experiments (1, 4, 11, 19, 20, 28). In
FIG 4 Klf3 expression increases during erythroid maturation. Expression lev-
els of Klf3 were examined by real-time qRT-PCR in sorted TER119 and
TER119 wild-type erythrocytes from E14.5 fetal liver. Shown are relative
expression levels for total Klf3 mRNA and also for transcripts emanating from
the widely active promoter 1a and the erythroid-cell-specific promoter 1b (8).
Relative expression was normalized against 18S rRNA, and the expression level
in TER119 cells was set to 1.0. For TER119 cells, n 4; for TER119 cells,
n 2 or 3. Error bars show standard errors of the means. P values indicate the
differences between two means: **, P	 0.01; ***, P	 0.001 (two-tailed t test).
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addition, we also performed our own Affymetrix microarrays on
three Eklf / and three Eklf / fetal livers (E13.5) to account for
annotation differences and possible absences of gene probe sets on
earlier microarray platforms. We then searched the list of putative
KLF3 target genes and found that a striking number of these (ap-
proximately 50%) are also regulated by EKLF (see Table S1 in the
supplemental material).
To further investigate the possible regulation of shared targets
FIG 5 KLF3 represses many genes in maturing TER119 erythroblasts. RNA was extracted from TER119 (four Klf3/ and four Klf3/) and TER119 (four
Klf3/and three Klf3/) sorted cell populations from E14.5 fetal liver and was subjected to Affymetrix microarray analysis. (A) Volcano plot comparing gene
expression in TER119 Klf3/ and Klf3/ cells. Data are for genes which are significantly differentially expressed (i.e., more than a 2-fold change) (P	 0.05;
FDR	 0.2). Red dots represent genes that are derepressed inKlf3/ cells, while blue dots represent genes that are downregulated. (B) Heat map comparing gene
expression in TER119 and TER119 Klf3/ and Klf3/ sorted erythroid cells. Heat maps represent the hierarchical clustering of the set of genes that are
significantly differentially expressed (as shown in panel A). Deregulated genes can broadly be grouped into three categories based on their expression during
erythroid maturation: genes that are mildly repressed or stable (set 1), upregulated (set 2), or strongly repressed or silenced (set 3) in TER119 compared to
TER119 wild-type cells. WT, wild type (Klf3/); KO, knockout (Klf3/).
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by EKLF and KLF3, we chose two genes, galectin-3 (Lgals3) and
adipolin (Fam132a), which are both highly derepressed in the
TER119 Klf3/ microarrays and have previously been identi-
fied as EKLF targets by ChIP-Seq (28). In hematopoietic tissue,
galectin-3 is a prominent mediator of inflammation and is most
strongly expressed in macrophages (10). Adipolin was recently
identified as an adipokine that influences insulin sensitivity and
glucose metabolism (6). We first sought to establish that these
genes are indeed functionally activated by EKLF. To do this, we
used the B1.6 cell line, an Eklf-null erythroid line which can be
rescued by a tamoxifen-inducible form of EKLF (2). Consistent
with functional regulation by EKLF, we found that expression of
both Lgals3 and Fam132a is highly induced when EKLF nuclear
activity is restored by tamoxifen addition to the cells (Fig. 7A and
C). Taken together with the ChIP-Seq studies, this suggests that
these genes are bona fide EKLF targets.
We then compared expression of Lgals3 and Fam132a in
TER119 erythroid progenitors and TER119 erythroblasts (Fig.
7B and D). We found that levels of Lgals3 and Fam132amRNA are
lower (2.8-fold and 10.1-fold, respectively) in TER119 than in
TER119 wild-type cells, consistent with transcriptional repres-
sion occurring as KLF3 levels increase during maturation. We also
observed significant derepression of Lgals3 and Fam132a tran-
scripts (15.5-fold and 11.1-fold, respectively) in Klf3/ com-
pared to Klf3/ TER119 erythroblasts. Furthermore, the dere-
pression of Lgals3 and Fam132a is much less pronounced in
TER119progenitors lacking KLF3 (1.4-fold and 2.3-fold, respec-
tively). This is consistent with our previous observation that KLF3
levels and activity are low in progenitor cells and again suggests
that the major role of KLF3 is to repress genes late in maturation.
The results above suggest that EKLF and KLF3 competitively
regulate Lgals3 and Fam132a at a functional level. We then asked
whether ChIP studies also supported direct competition. As de-
scribed above, previous ChIP-Seq studies indicated that EKLF
binds both the Lgals3 and Fam132a loci in vivo (28). In order to
determine whether KLF3 could also directly localize to these genes
in vivo, we designed primers proximal to the EKLF-bound sites in
these loci and then tested for KLF3 occupancy using ChIP. For
these studies we used a V5-tagged KLF3 transgene that had been
introduced into KLF3 null MEFs, which like erythroid cells and
many other cells normally abundantly express KLF3. We observed
very strong KLF3 occupancy at both the Lgals3 and Fam132 loci
(Fig. 7E). The Klf8 promoter served as a positive control in these
experiments, and a distal region upstream of the Klf8 gene was
used as a negative control (5). This combination of functional data
and occupancy as measured by ChIP analysis suggests that KLF3
directly counters the activity of EKLF at selected target genes.
Taken together, the derepression of numerous genes in
Klf3/ TER119 erythroid cells and the high degree of overlap
between these targets and those regulated by EKLF strongly sug-
gest that the primary erythroid function of KLF3 is to repress or
temper a subset of EKLF-inducible genes during erythroid matu-
ration. Ablation of KLF3 leads to deregulated gene expression and
erythroid impairments both in the fetus and the adult, indicating
that KLF3 is required for normal erythropoiesis in vivo.
DISCUSSION
Detailed analysis of erythropoiesis in Klf3/ mice revealed con-
sistent defects in red blood cell development. Peripheral blood
smears and full blood counts demonstrated reticulocytosis and
alterations in red blood cell numbers and mean cell hemoglobin
content, indicative of a mild anemia. Klf3/ spleens are enlarged
and exhibit a considerable increase in the proportion of red pulp.
Flow cytometry of splenic erythrocytes has shown a significant
increase in the proportion of CD71 TER119 erythroblasts, in-
dicating that loss of KLF3 leads to chronic compensatory stress
erythropoiesis in this organ. Erythroid defects are also apparent in
the fetal liver and bone marrow ofKlf3/mice. In summary, loss
of KLF3 leads to impairments in fetal and adult erythropoiesis,
resulting in an anemia which is stabilized by compensatory stress
erythropoiesis in the spleen.
Analysis of Klf3 gene expression during erythroid maturation
shows that Klf3 levels increase as TER119 progenitor cells ma-
ture to become TER119 erythroblasts. This view of KLF3 as a
late-stage repressor is further supported by recent ChIP-Seq and
RNA-Seq analyses examining EKLF activity during erythroid de-
velopment. KLF3 was recently confirmed as one of a set of EKLF
target genes that are bound by and activated by EKLF in TER119
erythroblasts (19). Accordingly, KLF3-mediated repression of
known target genes, such as Klf8 (5), increases as erythroid cells
mature, and loss of KLF3 has a more pronounced effect on gene
deregulation at this later stage of development.
When one considers the set of genes regulated by KLF3, a
number of things are apparent. Most notably, very few of the
genes are known to play major roles in erythropoiesis, and
there is a scarcity of genes with established erythroid roles, such
as Ahsp, Epb4.9, and Ermap (11). Nevertheless, approximately
half of the KLF3-dependent genes are previously reported
EKLF targets, albeit without recognized erythroid-cell-specific
functions. This is not entirely unexpected, in that the authors
of a recent EKLF ChIP-Seq study noted that a large number of
the genomic sites that are occupied by EKLF lie within or prox-
imal to genes with no known erythroid function (28). One
interpretation is that EKLF has evolved as a potent activator of
CACCC-dependent genes and accumulates during erythroid mat-
uration in order to activate targets that are essential in the later
stages of erythroid differentiation. It is possible that one side effect
of the potency of EKLF and its increasing activity during erythroid
FIG 6 Increased repression of the KLF3 target gene Klf8 during erythroid
maturation. Shown are relative Klf8 expression levels in Klf3/ and Klf3/
TER119 cells and in Klf3/, Klf3/ and Klf3/ TER119 cells. Relative
expression was normalized against 18S rRNA, and the expression level in
Klf3/ TER119 cells was set to 1.0. For TER119 cells, n 3; for TER119
cells, n 2 or 3. Error bars show standard errors of the means. WT, wild type
(Klf3/); KO, knockout (Klf3/).
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maturation is that it has the capacity to promiscuously activate the
transcription of nonerythroid CACCC-dependent genes. To
counter this, EKLF may activate KLF3 to silence a subset of genes
which have no specific role in erythroid cells and which, when
expressed as a cohort, may even be detrimental to these cells. In-
deed, many of the putative KLF3 target genes are either downregu-
lated or maintained at low, steady levels as TER119 progenitors
mature into TER119 erythroblasts (Fig. 5B). Given that KLF3 is
FIG 7 KLF3 and EKLF regulate shared target genes. Expression of Lgals3 (A) and Fam132a (C) increases upon tamoxifen (4-OHT)-induced rescue of EKLF in
the Eklf-null cell line B1.6 by real-time qRT-PCR. Relative expression was normalized against 18S rRNA, and the expression level in uninduced cells was set to 1.0
(n 3 for Lgals3 and 4 for Fam132a). Relative Lgals3 (B) and Fam132a (D) expression levels inKlf3/ (n 4) andKlf3/ (n 3) TER119 cells and inKlf3/
(n  2 or 3), Klf3/ (n  3) and Klf3/ (n  3) TER119 cells. Relative expression was normalized against 18S rRNA, and the expression level in Klf3/
TER119 cells was set to 1.0. (E) Chromatin immunoprecipitation assay showing binding of KLF3 at the Lgals3 and Fam132a loci. The ChIP assays were carried
out in duplicate in Klf3-null murine embryonic fibroblasts into which a V5-tagged Klf3 transgene had been introduced. Fold enrichment was determined by
real-time PCR and is relative to input signal. The enrichment at a site in theKlf8 locus where KLF3 has been reported to not bind (5) was set to 1.0.Klf8 promoter
1a was included as a positive control. Error bars show standard errors of the means. WT, wild type (Klf3/); KO, knockout (Klf3/).
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a broadly expressed transcription factor present not only in ery-
throid cells but also in fibroblasts and other cell types, it is possible
that KLF3 plays a global role in repressing these nonerythroid
genes.
Another interpretation is that some of the shared EKLF/KLF3
target genes may indeed have erythroid functions, which are as yet
undefined, and the role of KLF3 may simply be to fine-tune the
precise expression level of particular erythroid genes in a classical
negative-feedback loop. It is perhaps most likely that KLF3 does
both: fine-tuning and damping the expression of some EKLF tar-
get genes and silencing other genes to refine and limit the set of
EKLF targets, such that some CACCC box-dependent genes are
never expressed in erythroid cells (Fig. 8). The result is satisfying,
as it explains the superficially paradoxical situation where a
CACCC box-dependent activator, EKLF, drives a CACCC box-
dependent repressor which can counter its activity. Our results
now establish EKLF and KLF3 as a pair of positively and negatively
acting transcription factors that work together to orchestrate nor-
mal erythropoiesis in vivo.
In summary, our data indicate that KLF3 is highly expressed at
the later stages of erythroid cell maturation, where it is required to
repress a subset of EKLF target genes and thereby contribute to
normal erythropoiesis. Thus, the molecular role of KLF3 in ery-
throid cells is to temper the activity of EKLF at some CACCC-
dependent targets, thereby helping to refine the functional subset
of EKLF-responsive genes (Fig. 8). The erythroid defects observed
in the Klf3/mice demonstrate that KLF3 is required for normal
erythropoiesis, and we conclude that the impaired erythroid mat-
uration is due, at least in part, to the combined effects of the
derepression of a cohort of KLF3-dependent genes in KLF3-defi-
cient erythroid cells.
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